Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAF(V600) mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial
At the same time, the neurogenic process is finely regulated by extracellular signals acting in the neurogenic niche environment, which can change substantially in different organisms, or even in different regions or stages within the same organism
TrxR inhibition also leads to a prodifferentiation effect on the latently HIV-infected cells, driving them toward short-lived phenotypes (i.e., effector memory) and, ultimately, decreasing the viral reservoir
Reduced inflammation, improved tissue organization, and blood vessel formation become potentially visible on ultrasound or MRI